TPG-Axon Royalty Trust
Records under this name other than patents TPG-Axon Royalty Trust holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to TPG-Axon Royalty Trust
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,671,192 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs now held by Gilead Sciences, Inc. In force · High confidence | In force | High confidence | |
| US 7,732,595 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs now held by Gilead Sciences, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 7,683,037 | Myocardial Perfusion Imaging Method now held by Gilead Sciences, Inc. Lapsed on the fee record Ended Mar 23, 2022 · Medium confidence | Lapsed on the fee record | Ended Mar 23, 2022 | Medium confidence |
| US 7,655,636 | Use of A2A Adenosine Receptor Agonists now held by Gilead Sciences, Inc. Lapsed on the fee record Ended Feb 2, 2022 · Medium confidence | Lapsed on the fee record | Ended Feb 2, 2022 | Medium confidence |
| US 6,855,818 | C-Pyrazole A2A Receptor Agonists now held by Gilead Sciences, Inc. Term ended Term ended May 12, 2020 · Medium confidence | Term ended | Term ended May 12, 2020 | Medium confidence |
| US 7,109,180 | C-Pyrazole A2A Receptor Agonists now held by Gilead Sciences, Inc. Term ended Ended no later than Nov 14, 2019 · Low confidence | Term ended | Ended no later than Nov 14, 2019 | Low confidence |
| US 6,770,634 | C-Pyrazole A2A Receptor Agonists now held by Gilead Sciences, Inc. Term ended Ended no later than Jun 22, 2019 · Low confidence | Term ended | Ended no later than Jun 22, 2019 | Low confidence |
| US 7,144,872 | N-Pyrazole A2A Receptor Agonists now held by Gilead Sciences, Inc. Term ended Term ended Jun 22, 2019 · Medium confidence | Term ended | Term ended Jun 22, 2019 | Medium confidence |
| US 7,183,264 | N-Pyrazole A2A Receptor Agonists now held by Gilead Sciences, Inc. Term ended Term ended Jun 22, 2019 · Medium confidence | Term ended | Term ended Jun 22, 2019 | Medium confidence |
| US 7,553,823 | C-Pyrazole A2A Receptor Agonists now held by Gilead Sciences, Inc. Term ended Term ended Jun 22, 2019 · Medium confidence | Term ended | Term ended Jun 22, 2019 | Medium confidence |